NEW YORK (GenomeWeb News) - Neuromed has licensed an Aureus Pharma database for use in its drug-development programs, Aureus said today.
 
Under the agreement, Neuromed will use the company’s AurScope Ion Channel database to support development of its chronic pain drugs.
 
AurScope contains information from the scientific literature that can be used to study "all known" ion channels that apply to "all stages of the drug discovery process," Aureus said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.